The University of Maryland, Baltimore County Institutional Biosafety Committee (IBC) has been approved by the NIH Office of Biotechnology Activities. The IBC is responsible for ensuring that all recombinant DNA or synthetic nucleic acid moleculesresearch as well as research with transgenic animals and biohazardous materials (such as bacterium, fungi, algae, potential infectious agents and select agents) conducted at UMBC and sponsored by external/internal funding be performed in compliance with the NIH Guidelines and with proper concern for the safety of research personnel, the environment, and the surrounding communities.
Below are important items to consider when working with the IBC: Prior to working with any of the materials mentioned above, an investigator must submit an application form to the IBC and follow committee approval before any research begins. Information on IBC procedures application forms can be accessed using the following link: (http://research.umbc.edu/biosafety-institutional-biosafety-committee/).
It is also the responsibility of the investigator to ensure that the staff listed on the protocol have sufficient knowledge and are sufficiently trained and documented to safely perform the responsibilities for which they have been assigned. Information on biosafety training and training registration can be accessed using the following link: (http://research.umbc.edu/education-training/).
The UMBC IBC meets quarterly or as required by the IBC Chair. Submission of IBC applications to compliance@umbc.edu by the below deadlines will ensure a more efficient review of your registration. The meeting schedule for the 2015-16 academic year is as follows:
The IBC will meet: Applications must be submitted to ORPC no later than:
September 16, 2015 August 1, 2015
December 9, 2015 November 1, 2015
March 16, 2016 February 1, 2016
June 15, 2016 May 1, 2016
For further information and assistance in preparing IBC applications, please contact us at 5-2737 or compliance@umbc.edu.
